The Rybelsus Vision Loss Lawsuit is an active lawsuit See If You Qualify Rybelsus, an oral semaglutide prescribed to treat type 2 diabetes but commonly used for weight loss, has been linked to severe vision side effects, including blurry vision, vision loss, and blindness
In 2023, the American Society of Anesthesiologists issued more specific recommendations: discontinuation 1 day prior to surgery for patients using daily formulations, and 1 week prior for weekly formulations
ALC also maintains healthy body fat and muscle composition in ageing individuals
But that hasnt stopped people from going to some extreme measures to get the drug, even after the FDA warned against using shortcuts like compounding pharmacies or telehealth programs
Side Effect Profiles: All Tirzepatide Forms (Same Side Effects): Nausea: 30-37% Diarrhea: 19-23% Vomiting: 9-17% Constipation: 10-17% Abdominal pain: 8-11% All Semaglutide Forms (Same Side Effects): Nausea: 44% Diarrhea: 30% Vomiting: 24% Constipation: 24% Abdominal pain: 20% Side effects are determined by the medication molecule, not the manufacturer